Tech Company Financing Transactions

Adcytherix Funding Round

Adcytherix, based in Marseille, secured $122 million in funding from Andera Partners, Angelini Ventures and Bpifrance.

Transaction Overview

Company Name
Adcytherix
Announced On
10/16/2025
Transaction Type
Venture Equity
Amount
$122,000,000
Round
Series A
Investors

Andera Partners (Lead Investor) (Sofia Ioannidou)

Angelini Ventures (Lead Investor) (Regina Hodits)

Bpifrance (Lead Investor) (Laurent Higueret)

InnoBio Fund (Lead Investor) (Olivier Martinez)

Kurma Partners (Lead Investor) (Peter Neubeck)

aMoon Fund

Surveyor Capital

Proceeds Purpose
The funding will enable the company to advance its lead candidate ADCX-020 into the clinic, with first investigational new drug (IND - US) and clinical trial applications (CTA -- EU, UK and Canada) filings planned by end 2025. In parallel, Adcytherix will expand its pipeline of proprietary ADCs using novel payloads.

Company Information

Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
17 boulevard Augustin Cieussa
Marseille, 13007
France
Phone
Undisclosed
Website
www.adcytherix.com
Email Address
[email protected]
Overview
Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer. The company is led by a seasoned management team and is supported by a network of world-leading experts in the field of ADC development.
Profile
Adcytherix LinkedIn Company Profile
Social Media
Adcytherix Company Twitter Account
Company News
Adcytherix News
Facebook
Adcytherix on Facebook
YouTube
Adcytherix on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jack Elands
  Jack Elands LinkedIn Profile  Jack Elands Twitter Account  Jack Elands News  Jack Elands on Facebook
Chief Financial Officer
Carsten Dehning
  Carsten Dehning LinkedIn Profile  Carsten Dehning Twitter Account  Carsten Dehning News  Carsten Dehning on Facebook
VP - Operations
Thierry Menguy
  Thierry Menguy LinkedIn Profile  Thierry Menguy Twitter Account  Thierry Menguy News  Thierry Menguy on Facebook
VP - R & D
Xavier Preville
  Xavier Preville LinkedIn Profile  Xavier Preville Twitter Account  Xavier Preville News  Xavier Preville on Facebook

 

 

Browse more venture capital transactions:

Prev: 10/16/2025: Veradermics venture capital transaction
Next: 10/16/2025: OneLayer venture capital transaction

 

Share this article

 

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2025. Gaebler Ventures. All rights reserved.